Literature DB >> 4917978

Clinical studies with tubercidin administered by direct intravenous injection.

H F Bisel, F J Ansfield, J H Mason, W L Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4917978

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis.

Authors:  M H el Kouni; D Diop; P O'Shea; R Carlisle; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

2.  Phase II study of chlorozotocin in islet cell carcinoma. A southwest Oncology Group study.

Authors:  R M Bukowski; J D McCracken; S P Balcerzak; C J Fabian
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Uncoupling of nucleo-cytoplasmic RNA export and localization during stress.

Authors:  Hodaya Hochberg-Laufer; Avital Schwed-Gross; Karla M Neugebauer; Yaron Shav-Tal
Journal:  Nucleic Acids Res       Date:  2019-05-21       Impact factor: 16.971

4.  Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death.

Authors:  Ligia I Bastea; Laeticia M A Hollant; Heike R Döppler; Elizabeth M Reid; Peter Storz
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

5.  First Total Synthesis of 5'-O-α-d-Glucopyranosyl Tubercidin.

Authors:  Wenliang Ouyang; Haiyang Huang; Ruchun Yang; Haixin Ding; Qiang Xiao
Journal:  Mar Drugs       Date:  2020-07-29       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.